PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Sartorius Stedim Biotech SA (DIM.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0013154002
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap€27.25B
EPS€3.36
PE Ratio83.33
PEG Ratio112.19
Revenue (TTM)€2.78B
Gross Profit (TTM)€1.83B
EBITDA (TTM)€657.80M
Year Range€160.55 - €310.80
Target Price€259.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with DIM.PA

Sartorius Stedim Biotech SA

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Sartorius Stedim Biotech SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%OctoberNovemberDecember2024FebruaryMarch
47,634.30%
366.84%
DIM.PA (Sartorius Stedim Biotech SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

Sartorius Stedim Biotech SA had a return of 9.52% year-to-date (YTD) and -12.15% in the last 12 months. Over the past 10 years, Sartorius Stedim Biotech SA had an annualized return of 27.00%, outperforming the S&P 500 benchmark which had an annualized return of 10.96%.


PeriodReturnBenchmark
Year-To-Date9.52%10.04%
1 month6.45%3.53%
6 months18.15%22.79%
1 year-12.15%32.16%
5 years (annualized)18.31%13.15%
10 years (annualized)27.00%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.89%1.23%
2023-7.87%-13.77%-21.88%16.91%16.04%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Sartorius Stedim Biotech SA (DIM.PA) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
DIM.PA
Sartorius Stedim Biotech SA
-0.16
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Sartorius Stedim Biotech SA Sharpe ratio is -0.16. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.16
2.75
DIM.PA (Sartorius Stedim Biotech SA)
Benchmark (^GSPC)

Dividends

Dividend History

Sartorius Stedim Biotech SA granted a 0.55% dividend yield in the last twelve months. The annual payout for that period amounted to €1.44 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€1.44€1.44€1.26€0.68€0.34€0.57€0.46€0.42€0.33€0.22€0.20€0.18

Dividend yield

0.55%0.60%0.42%0.14%0.12%0.39%0.53%0.70%0.56%0.37%0.74%0.90%

Monthly Dividends

The table displays the monthly dividend distributions for Sartorius Stedim Biotech SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024€0.00€0.00
2023€0.00€0.00€1.44€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00€1.26€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2021€0.00€0.00€0.68€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2020€0.00€0.00€0.00€0.00€0.00€0.34€0.00€0.00€0.00€0.00€0.00€0.00
2019€0.00€0.00€0.57€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2018€0.00€0.00€0.00€0.46€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2017€0.00€0.00€0.00€0.42€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2016€0.00€0.00€0.00€0.33€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2015€0.00€0.00€0.00€0.22€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2014€0.00€0.00€0.00€0.20€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2013€0.18€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%0.6%
Sartorius Stedim Biotech SA has a dividend yield of 0.55%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%42.9%
Sartorius Stedim Biotech SA has a payout ratio of 42.86%, which is quite average when compared to the overall market. This suggests that Sartorius Stedim Biotech SA strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-51.76%
0
DIM.PA (Sartorius Stedim Biotech SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Sartorius Stedim Biotech SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sartorius Stedim Biotech SA was 76.82%, occurring on Dec 18, 2008. Recovery took 647 trading sessions.

The current Sartorius Stedim Biotech SA drawdown is 51.76%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.82%Jun 19, 2007377Dec 18, 2008647Jun 30, 20111024
-74.01%Jul 17, 1997520Aug 19, 1999330Dec 6, 2000850
-71.02%May 10, 2002109Oct 9, 2002584Jan 19, 2005693
-70.21%Sep 13, 2021550Oct 30, 2023
-31.8%Jul 17, 200150Sep 24, 2001153May 6, 2002203

Volatility

Volatility Chart

The current Sartorius Stedim Biotech SA volatility is 8.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%OctoberNovemberDecember2024FebruaryMarch
8.90%
2.79%
DIM.PA (Sartorius Stedim Biotech SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sartorius Stedim Biotech SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items